A Modified Adenovirus Vector–Mediated Antibody Screening Method Identifies EphA2 as a Cancer Target
Open Access
- 1 August 2017
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 10 (4) , 476-484
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Carcinoembryonic Antigen–Targeted Selective Gene Therapy for Gastric Cancer through FZ33 Fiber-Modified Adenovirus VectorsClinical Cancer Research, 2006
- Eph receptor signalling casts a wide net on cell behaviourNature Reviews Molecular Cell Biology, 2005
- Eph receptors in the adult brainCurrent Opinion in Neurobiology, 2004
- Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and CancersClinical Chemistry, 2004
- RETRACTED ARTICLE: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinomaOncogene, 2004
- `Eph'ective signaling: forward, reverse and crosstalkJournal of Cell Science, 2003
- Mechanisms and functions of eph and ephrin signallingNature Reviews Molecular Cell Biology, 2002
- THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENTAnnual Review of Neuroscience, 1998
- Ephrins and their receptors: a repulsive topic?Cell and tissue research, 1997
- The Eph family of receptorsCurrent Opinion in Cell Biology, 1997